Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds for Medium Supplement

Items 1-10 of 16

Page
per page
  1. A 83-01
    A3133 A 83-01
     11 Citation
    Summary: ALK inhibitor
      ≥21.1 mg/mL
  2. Prostaglandin E2
    B7005 Prostaglandin E2
     2 Citation
    Target: Prostaglandin EP receptors
    Summary: Endogenous prostaglandin
      ≥35.2 mg/mL
  3. Gastrin I (human)
    B5358 Gastrin I (human)
    Summary: selective CCK2 receptor agonist
      insoluble in H2O; insoluble in EtOH; ≥21 mg/mL
  4. DAPT (GSI-IX)
    A8200 DAPT (GSI-IX)
     20 Citation
    Summary: γ-secretase inhibitor
      ≥21.62 mg/mL
  5. GDC-0068 (RG7440)
    A3006 GDC-0068 (RG7440)
     2 Citation
    Target: Akt
    Summary: Pan-AKT inhibitor,highly selective
      ≥22.9 mg/mL
  6. Y-27632 dihydrochloride
    A3008 Y-27632 dihydrochloride
     75 Citation
    Target: ROCK
    Summary: ROCK inhibitor
      ≥111.2 mg/mL
  7. MK-2206 dihydrochloride
    A3010 MK-2206 dihydrochloride
     52 Citation
    Target: Akt
    Summary: Akt1/2/3 inhibitor
      insoluble in EtOH; ≥12.01 mg/mL
  8. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     30 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor
      ≥23.27 mg/mL
  9. G418 Sulfate (Geneticin, G-418)
    A2513 G418 Sulfate (Geneticin, G-418)
     7 Citation
    Target: Ribosomes
    Summary: Geneticin, G-418 Sulfate
      insoluble in EtOH; insoluble in DMSO; ≥64.6 mg/mL
  10. Nicotinamide
    N1651 Nicotinamide
     1 Citation
    Target: PARP
    Summary: PARP-1 inhibitor

Items 1-10 of 16

Page
per page